A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Afatinib (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results (n=49) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 05 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 05 Sep 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.